Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wasan

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
BMC Cancer|October 24, 2015
Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectumR Glynne-Jones, N Hava, V Goh, et al.
British Journal of Cancer|April 20, 2022
First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 studyE Van Cutsem, I Danielewicz, M P Saunders, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 5, 2020
Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 studyE Van Cutsem, I Danielewicz, M P Saunders, et al.
British Journal of Cancer|May 1, 2020
Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinomaP G Corrie, W Qian, B Basu, et al.
ESMO Open|June 1, 2023
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022M Ducreux, G K Abou-Alfa, T Bekaii-Saab, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2016
ESMO consensus guidelines for the management of patients with metastatic colorectal cancerE Van Cutsem, A Cervantes, R Adam, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
BMC Cancer|October 24, 2015
Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectumR Glynne-Jones, N Hava, V Goh, et al.
British Journal of Cancer|April 20, 2022
First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 studyE Van Cutsem, I Danielewicz, M P Saunders, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 5, 2020
Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 studyE Van Cutsem, I Danielewicz, M P Saunders, et al.
British Journal of Cancer|May 1, 2020
Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinomaP G Corrie, W Qian, B Basu, et al.
ESMO Open|June 1, 2023
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022M Ducreux, G K Abou-Alfa, T Bekaii-Saab, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2016
ESMO consensus guidelines for the management of patients with metastatic colorectal cancerE Van Cutsem, A Cervantes, R Adam, et al.
Pageof 4